summary
Introduced
04/26/2021
04/26/2021
In Committee
04/27/2021
04/27/2021
Crossed Over
Passed
Dead
01/03/2023
01/03/2023
Introduced Session
117th Congress
Bill Summary
A BILL To amend title XVIII of the Social Security Act to require the Secretary of Health and Human Services to add a new set of measures to the 5-star rating system under the Medicare Advantage program in order to encourage increased access to biosimilar biological products.
AI Summary
This bill, the Star Rating for Biosimilars Act, would require the Secretary of Health and Human Services to add new measures to the 5-star rating system under the Medicare Advantage program to encourage increased access to biosimilar biological products. The new measures would assess factors such as the coverage, cost-sharing, utilization management tools, and overall utilization of biosimilars compared to their reference biological products. The goal is to ensure patients have equal access to appropriate therapeutic options without undue administrative burden.
Committee Categories
Business and Industry, Health and Social Services, Labor and Employment
Sponsors (2)
Last Action
Referred to the Subcommittee on Health. (on 04/27/2021)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.congress.gov/bill/117th-congress/house-bill/2855/all-info |
| BillText | https://www.congress.gov/117/bills/hr2855/BILLS-117hr2855ih.pdf |
| Bill | https://www.congress.gov/117/bills/hr2855/BILLS-117hr2855ih.pdf.pdf |
Loading...